BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 36835039)

  • 1. Gene Therapy of Sphingolipid Metabolic Disorders.
    Shaimardanova AA; Solovyeva VV; Issa SS; Rizvanov AA
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
    Inui K; Wenger DA
    J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare Diseases in Glycosphingolipid Metabolism.
    Zhou H; Wu Z; Wang Y; Wu Q; Hu M; Ma S; Zhou M; Sun Y; Yu B; Ye J; Jiang W; Fu Z; Gong Y
    Adv Exp Med Biol; 2022; 1372():189-213. PubMed ID: 35503182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Sphingolipidoses: CRISPR-Cas9 Editing as an Option for Modelling and Therapy.
    Santos R; Amaral O
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic abnormalities in diseases of sphingolipid metabolism.
    Brady RO
    Clin Chem; 1967 Jul; 13(7):565-77. PubMed ID: 5006481
    [No Abstract]   [Full Text] [Related]  

  • 6. The sphiningolipidoses: an overview.
    West HH
    Postgrad Med; 1977 Mar; 61(3):90-3, 95. PubMed ID: 402652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal storage diseases.
    Ferreira CR; Gahl WA
    Transl Sci Rare Dis; 2017 May; 2(1-2):1-71. PubMed ID: 29152458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingolipidoses in Turkey.
    Ozkara HA; Topçu M
    Brain Dev; 2004 Sep; 26(6):363-6. PubMed ID: 15275696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent advances in sphingolipidosis research].
    Tamai Y; Kojima H
    Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1291-303. PubMed ID: 1972585
    [No Abstract]   [Full Text] [Related]  

  • 10. Basic findings and current developments in sphingolipidoses.
    Pilz H; Heipertz R; Seidel D
    Hum Genet; 1979 Mar; 47(2):113-34. PubMed ID: 108196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease.
    Paciotti S; Albi E; Parnetti L; Beccari T
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32098196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From sheep to mice to cells: tools for the study of the sphingolipidoses.
    Zigdon H; Meshcheriakova A; Futerman AH
    Biochim Biophys Acta; 2014 Aug; 1841(8):1189-99. PubMed ID: 24607565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited lipid storage diseases of the central nervous system.
    Percy AK; Shapiro LJ; Kaback MM
    Curr Probl Pediatr; 1979 Sep; 9(11):1-51. PubMed ID: 117977
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular facets of sphingolipids: mediators of diseases.
    Ozbayraktar FB; Ulgen KO
    Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid storage disease: Part III. Ultrastructural evaluation of cultured fibroblasts in sphingolipidoses.
    Takahashi K; Naito M; Suzuki Y
    Acta Pathol Jpn; 1987 Feb; 37(2):261-72. PubMed ID: 3037847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann-Pick disease type C.
    Platt FM
    Biochem Soc Trans; 2023 Oct; 51(5):1777-1787. PubMed ID: 37844193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saul R. Korey Lecture. Molecular genetics of Tay-Sachs and related disorders: a personal account.
    Suzuki K
    J Neuropathol Exp Neurol; 1994 Jul; 53(4):344-50. PubMed ID: 8021707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances and novel treatments for sphingolipidoses.
    Arenz C
    Future Med Chem; 2017 Sep; 9(14):1687-1700. PubMed ID: 28857617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biochemistry of sphingolipid storage diseases.
    Sandhoff K
    Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study.
    Polo G; Burlina AP; Ranieri E; Colucci F; Rubert L; Pascarella A; Duro G; Tummolo A; Padoan A; Plebani M; Burlina AB
    Clin Chem Lab Med; 2019 Nov; 57(12):1863-1874. PubMed ID: 31091195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.